Clinical Trial Update: NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases [NA]

View source ↗

Summary

A pilot study compares NIVATS and IGAVATS for biopsy quality in undetermined interstitial lung diseases and is currently recruiting in Montpellier.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Lung Diseases, Interstitial | NA | Status: RECRUITING